Skip to main content
PHAT
NASDAQ Life Sciences

Q3 Revenue Jumps 71% to $84.7M as Phathom Turns Adjusted Profit, Reaffirms Guidance

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$6.65
Mkt Cap
$508.058M
52W Low
$5.015
52W High
$18.31
52W Position info
33% above low
Off High info
64% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

PHAT sits 33% above its 52-week low of $5.015.

Summary

Phathom posted Q3 2026 net revenue of $84.7 million, up 71% from $49.5 million a year ago, and swung to non-GAAP adjusted net income of $3.0 million from a $11.2 million adjusted loss. Operating loss narrowed to just $85 thousand, and the company generated positive cash flow from operations for a second straight quarter. Cash stood at $184.6 million at September 30, up $2.1 million sequentially, and management says that plus expected operating cash is enough to fund the business and service all debt without new financing. Full-year 2026 guidance was maintained at $310-325 million in net revenue and $235-245 million in non-GAAP operating expenses. On the legal front, the D.C. district court granted Phathom's motion to intervene in BDR's suit against the FDA over VOQUEZNA's NCE exclusivity on October 26, following the FDA's October 23 public comment docket with comments due November 23. Next catalysts: EoE Phase 2 topline data expected in Q4 2026, with the NERD as-needed Phase 3 reading out in Q1 2028.

At the time of this announcement, PHAT was trading at $6.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $508.1M. The 52-week trading range was $5.02 to $18.31. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

PHAT - Latest Insights

PHAT
Oct 29, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.65
Real-time Price: $6.27 info
Change: -$0.3793 (-6%) info
Market Cap: $506.446M info
PHAT
Oct 26, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.50
Real-time Price: $6.27 info
Change: +$0.7707 (+14%) info
Market Cap: $506.446M info
PHAT
Oct 26, 2026, 4:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $5.50
Real-time Price: $6.27 info
Change: +$0.7707 (+14%) info
Market Cap: $506.446M info
PHAT
Oct 23, 2026, 4:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $6.86
Real-time Price: $6.27 info
Change: -$0.5893 (-9%) info
Market Cap: $506.446M info
PHAT
Sep 29, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.30
Real-time Price: $6.27 info
Change: -$1.03 (-14%) info
Market Cap: $506.446M info